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0022-2836/$ - see front matter © 2008 EThe precursor mRNA retention and splicing (RES) complex mediates
nuclear retention and enhances splicing of precursor mRNAs. The RES
complex from yeast comprises three proteins, Snu17p, Bud13p and Pml1p.
Snu17p acts as a central platform that concomitantly binds the Bud13p and
Pml1p subunits via short peptide epitopes. As a step to decipher the
molecular architecture of the RES complex, we have determined crystal
structures of full-length Pml1p and N-terminally truncated Pml1p. The first
50 residues of full-length Pml1p, encompassing the Snu17p-binding region,
are disordered, showing that Pml1p binds to Snu17p via an intrinsically
unstructured region. The remainder of Pml1p folds as a forkhead-associated
(FHA) domain, which is expanded by a number of noncanonical elements
compared with known FHA domains from other proteins. An atypical
N-terminal appendix runs across one β-sheet and thereby stabilizes the
domain as shown by deletion experiments. FHA domains are thought to
constitute phosphopeptide-binding elements. Consistently, a sulfate ion
was found at the putative phosphopeptide-binding loops of full-length
Pml1p. The N-terminally truncated version of the protein lacked a similar
phosphopeptide mimic but retained an almost identical structure. A long
loop neighboring the putative phosphopeptide-binding site was disordered
in both structures. Comparison with other FHA domain proteins suggests
that this loop adopts a defined conformation upon ligand binding and
thereby confers ligand specificity. Our results show that in the RES complex,
an FHA domain of Pml1p is flexibly tethered via an unstructured
N-terminal region to Snu17p.
© 2008 Elsevier Ltd. All rights reserved.Keywords: intrinsically unstructured domain; forkhead-associated domain;
pre-mRNA retention and splicing; protein phosphorylation; RES complexEdited by R. HuberIntroduction
During precursor mRNA (pre-mRNA) splicing in
eukaryotes, noncoding intervening sequences








lsevier Ltd. All rights reserveregions (exons) are ligated to produce mature mRNA
that can serve as a template for protein biosynthesis.
Each round of splicing entails two sequential trans-
esterification reactions that are carried out by a large,
multifactorial RNA–protein enzyme, the spliceo-
some.1–4 The main task of the spliceosome lies in
locating and bringing together the sites at which the
cut-and-paste reactions have to proceed with single-
nucleotide precision. A spliceosome is assembled de
novo for each splicing event by the stepwise stable
integration of small nuclear ribonucleoprotein parti-
cles (snRNPs) and numerous non-snRNP splice fac-
tors to accomplish this task.1 Five snRNAs and more
than 150 proteins participate in this process.2 After
the assembly of all snRNPs, major compositional and
conformational rearrangements are required to bringd.
532 Structure of Pml1pabout a catalytically competent particle that is
correctly positioned on the pre-mRNA substrate.1–5
Many of the spliceosomal constituents are pre-
organized as functional modules. Prime among
such modules are the snRNPs, each of which com-
prises a particular snRNA, a set of seven common
Sm proteins (Sm-like, LSm, proteins in the case of
U6) and a variable number of particle-specific pro-
teins.4 In addition, many of the non-snRNP splice
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f ESU=estimated overall coordinate error based on maximum likel
g Calculated with MolProbity (http://molprobity.biochem.duke.ed
h RMSD – root-mean-square deviation.cases, specific functions could be attributed to these
modules. For example, the pre-mRNA retention and
splicing (RES) complex, a recently discovered splice-
osome-associated module in yeast, is involved in
retaining unspliced pre-mRNAs in the nucleus and
in splicing a subset of pre-mRNAs.6–8 The RES
complex encompasses proteins Snu17p, Bud13p
and Pml1p.6 Recently, we have used structural,
biochemical and biophysical techniques to work
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533Structure of Pml1pcomponents.9 Snu17p harbors an unusual RNA
recognition motif (RRM) that presents two separate
binding sites for short peptides in the C-terminus of
Bud13p and in the N-terminus of Pml1p. This
organization leaves the bulk of Bud13p and Pml1p
available to engage in other activities.
Sequence analysis suggested that the C-terminal
half of Pml1p, which is not involved in Snu17p
binding, harbors a forkhead-associated (FHA) do-
main. Here, we elucidated the crystal structures of
full-length Pml1p and a truncated form lacking the
first 50 residues. The N-terminal part of Pml1p is
invisible in the structure of the full-length protein
and exerts no influence on the structure in the
C-terminal part. The latter portion exhibits an FHA
domain fold that is expanded by a number of nonca-
nonical elements compared with other known FHA
domains. In one crystal structure, a sulfate ion binds
at a site equivalent to the phosphopeptide-binding
site in other FHA domains. Our results support the
idea that Pml1p acts as a sensor of phosphorylation
marks that is recruited to the spliceosome via an
intrinsically unstructured N-terminal region.
Results
Structure determination and quality of the
models
Although biochemical and biophysical analyses
had indicated disorder in the N-terminal region of
Pml1p,9 well-diffracting crystals were obtained
from the full-length protein. Pml1p crystallized in
space group P3221 with two monomers per asym-
metric unit. We solved its structure at 2.4-Å reso-
lution via the single anomalous diffraction (SAD)Fig. 1. Structural overview. The structure of full-length P
shown in blue; helices, in red; and loops, in gray. Secondary str
is shown as sticks (sulfur is shown in yellow; oxygen, in red)
density are drawn as dashed lines. “C” indicates C-terminus; “
indicated. All structure figures were prepared using the progmethod, using the anomalous scattering of a mer-
cury derivative (Table 1). The final refined model
exhibited Rwork and Rfree values of 21.8% and 26.6%,
respectively, with all residues in the favored or
additionally allowed regions of the Ramachandran
plot (Table 1).
We also determined the crystal structure of
Pml1p51–204, a truncated version, lacking the 50 N-
terminal residues. Pml1p51–204 crystallized in space
group H32 with one molecule per asymmetric unit.
Its structure was refined at 1.8-Å resolution with
Rwork and Rfree values of 18.9% and 23.6%, respec-
tively, again retaining good stereochemistry (Table 1).
Overall structure
Apart from a long, flexible loop (residues 112–121),
amino acids 52–204 could bemodeled unequivocally
into the electron density map of full-length Pml1p
(Fig. 1; because 10 residues in the flexible loop are
disordered, it is referred to as the Δ10 loop in the
following). The remaining N-terminal part (residues
1–51) could not be traced, although the crystals
contained the intact polypeptide chain (Supplemen-
tary Fig. 1a). This finding confirmed the results of our
biochemical analyses,9 suggesting that the first 51 resi-
dues of Pml1p are unstructured in the isolated protein.
A VAST homology search10 showed that the
ordered portion of Pml1p resembles an FHAdomain
fold (Fig. 1). This portion of the protein comprises a
short N-terminal α-helix and a sandwich of two
twisted β-sheets (strands β1/β2/β7/β8/β10/β11
and strands β3/β4/β5/β6/β9; Fig. 1). Strands β3
and β4 run parallel with each other, and all re-
maining β-strands are antiparallel. Two short 310
helices are inserted between the N-terminal α-helix
and strand β1 and between strandsβ10 and β11. Theml1p is shown in cartoon representation. β-Strands are
ucture elements are numbered. The coordinated sulfate ion
. Unstructured regions in the protein showing no electron
N,”N-terminus. The view on the right is rotated by 90° as
ram PyMOL [http://www.pymol.org].
534 Structure of Pml1pstructures of the full-length Pml1p and truncated
Pml1p were highly similar (Fig. 1 and Supplemen-
tary Fig. 2), exhibiting a root-mean-square deviation
(RMSD) of 0.7 Å for 144 Cα atoms. The flexible Δ10
loop of full-length Pml1p, suspended between
strands β3 and β4, was likewise disordered in the
structure of the truncated protein. A third 310 helix
was found between β1 and β2 in truncated Pml1p.
Crystals of full-length Pml1p contained two mole-
cules in an asymmetric unit, which were related by a
local 2-fold axis, forming a V-shaped pseudo-dimer
(Supplementary Fig. 1b). Crystals of the truncated
protein showed a similar mode of dimerization via a
crystallographic 2-fold axis. Nevertheless, this
apparent higher oligomeric state of Pml1p is most
likely a consequence of crystal packing, since gel
filtration indicated that the protein is monomeric in
solution (Supplementary Fig. 1c).Fig. 2. Global comparison of FHA domains from various pr
VAST structure-based analysis10 are shown in gray. Protein
structure elementswere assigned using theDSSP algorithm (sec
18). There are prominent N- and C-terminal extensions in Pml1
in Chk2. The small EmbR FHA domain (upper left) has neith
domains are similarly expanded at the N-termini. “C” indica
ligands. Models are rotated 70° around the x-axis and 10° arouThe Pml1p FHA domain is expanded by
noncanonical elements
The Pml1p FHA domain (152 amino acids) is
considerably larger than most other FHA domain
structures determined so far. For example, FHA
domains from the yeast checkpoint protein Rad53p
(FHA111), its human homolog Chk2,12 the mitotic
checkpoint protein Chfr,13 mammalian polynucleo-
tide kinase (PNK14), the antigen identified by
monoclonal antibody Ki-67 (Ki6715), Arabidopsis
thaliana receptor kinase-associated protein phospha-
tase (KAPP16) and the putative transcriptional
regulator EmbR17 encompass between 95 and 123
residues. The increased length of the Pml1p FHA
domain is accounted for by several structural
insertions and appendices (Fig. 2). Compared with
the FHA domains of EmbR, one of the shortestoteins. The regions common to the domains according to a
-specific elements are differentially colored. Secondary
ondary structural elements forNIPP1were taken fromRef.
p, Rad53p FHA1 and Rad53p FHA2 and a helical insertion
er extensions nor insertions. The Pml1p and NIPP1 FHA
tes C-terminus; “N,” N-terminus; P-pep, phosphopeptide
nd the y-axis relative to the orientation in Fig. 1 (left).
535Structure of Pml1pknown FHA domains, Pml1p exhibits an N-terminal
appendix (residues 52–61) that lacks a regular
secondary structure, an elongated loop between β1
and β2, the long unstructured Δ10 loop inserted
between strands β3 and β4 and a helical insertion
between β10 and β11 (Figs. 1 and 2). In other FHA
domains, different structural elements have been
found in addition to the core fold (Fig. 2). For
example, the second Rad53p FHA domain shows an
extended α-helical C-terminal region, which runs
across one of the β-sheets,19 and a long insertion
connecting strands β5 and β6.
The N-terminal appendix is crucial for the
integrity of the Pml1p FHA domain
Residues 52–61 of Pml1p lie like a clamp on top of
strands β3 and β5 (Figs. 2 and 3a). The peptide
thereby positions helix α1, which in turn stabilizes
the loop between β2 and β3 by hydrogen bonds.
Interestingly, a similar N-terminal expansion is seen
in the NIPP1 FHA domain but not in other FHA
domain proteins analyzed to date (Figs. 2 and 3a).
Crucial residues by which the peptide is fastened
to the β-sheet are conserved in NIPP1 and Pml1p
(Fig. 4a and b). We tested the importance of the
N-terminal peptide for the integrity of the FHA
domain by generating a truncated Pml1p variant
lacking the first 61 residues. Pml1p62–204 exhibited
dramatically reduced solubility compared with
the full-length protein, Pml1p34–204 (Fig. 3b) and
Pml1p51–204 (data not shown). Therefore, the
N-terminal appendix confers critical stability on
the Pml1p FHA domain. Similar stabilizing appen-
dices that wrap around a core domain have recently
been seen in the Prp8p Jab1/MPN domain.20,21
The Pml1p FHA domain exhibits hallmarks of a
phosphopeptide-binding element
Several FHA domains have been shown to
function as phosphopeptide-binding modules.11
Six residues that are highly conserved amongwith Fig. 1 (left). (b) Full-length Pml1p and N-terminally trun
conditions in E. coli. Proteins were captured on Ni2+-NTA agaro
via SDS-PAGE. Lane 1, Pml1p1–204 (full length); lane 2, Pml
extension of Pml1p (residues 51–61) renders the protein insoluphosphopeptide-binding FHA proteins are also
found in Pml1p (Gly107, Arg108, Ser137, His140,
Asn163 and Asn168). With the exception of Asn168,
which is thought to stabilize the structure, these
residues lie in surface loops that come together at
one edge of the FHA domain (Fig. 5a). Significantly,
a sulfate ion is bound to this region in the full-length
Pml1p structure, possibly mimicking a phospho-
amino acid group (Fig. 5a). The sulfate most likely
originates from the Li2SO4 contained in the crystal-
lization buffer. Other FHA domains have also been
observed to coordinate phosphate mimics in the
absence of phosphopeptide ligands, such as a
tungstate ion in the case of Chfr13 (Fig. 5a).
The conserved Gly107, Ser137, His140 and Asn163
do not directly interact with the sulfate ion but
reinforce the productive conformation of the sulfate-
binding region. The highly conserved Arg108 in
loop β3–β4 engages in two salt bridges to sulfate
oxygens. The orientation of Arg108 with respect to
the sulfate ion resembles the disposition of analo-
gous arginines in phosphopeptide-binding FHA
domains.13,22 The conformations of the putative
phosphopeptide-binding loops of Pml1p are very
similar in the full-length and truncated Pml1p
structures, although the latter structure lacks a
sulfate ion (Fig. 5b; the crystallization buffer of
truncated Pml1p did not contain sulfate). Indepen-
dent of the sulfate, Arg108 seems to be held in place
by Ser136.
Work on the FHA domain of A. thaliana KAPP
suggested that loops forming the phosphopeptide-
binding region rigidify upon ligand binding.23
Similarly, loop regions in the FHA domain of Ki67
have been shown to adopt a fixed structure in the
presence of a binding partner.15 NMR chemical shift
changes have indicated a similar situation in NIPP1,
where several loops are restructured upon phos-
phopeptide binding.18 One of these loops corre-
sponds to the flexible Δ10 loop of Pml1p, which
neighbors the sulfate-binding site (Fig. 6). The Δ10
loop is rich in acidic residues (Fig. 4a). Similar acidic
insertions are only seen in Pml1p orthologs and areFig. 3. Structure and function of
an N-terminal extension in Pml1p.
(a) Superposition of Pml1p (dark
gray) and NIPP1 (light gray) re-
veals a conserved N-terminal exten-
sion in the structures. Highly con-
served residues are shown as sticks
(Pml1p is shown in green; NIPP1, in
blue). Some secondary structure
elements of Pml1p are labeled for
clarity. “C” indicates C-terminus;
“N,” N-terminus. Models are ro-
tated 100° around the z-axis (into
the plane of the paper) compared
cated fragments of Pml1p were produced under identical
se from soluble extract, and eluted proteins were analyzed
1p34–204; lane 3, Pml1p62–204. Removal of the N-terminal
ble.
Fig. 4. Multiple-sequence alignments. (a) Multiple-sequence alignment of Saccharomyces cerevisiae Pml1p (Sc; accession code NP_013116.1) with orthologs from Kluyveromyces
lactis (Kl; XP_453486.1), Ashbya gossypii (Ag; NP_983442.1) and Candida glabrata (Cg; XP_445545.1). Darker background corresponds to higher conservation. TheΔ10 loop of Pml1p
is marked by a yellow dashed line. Green characters indicate conserved residues, which seem to be crucial for Pml1p stability. Asterisks mark conserved residues that are
important for phosphopeptide binding in other FHA domains. (b) Multiple structure-based sequence alignment of the FHA domain structures of Pml1p (this study), NIPP1
[Protein Data Bank (PDB) ID 2JPE], Rad53p FHA2 (PDB ID 1FHR), Rad53p FHA1 (PDB ID 1G6G) and EmbR (PDB ID 2FF4). Sequences were aligned using the VAST server and
adjusted manually. The N-terminal appendices of Pml1p and NIPP1 are indicated. Secondary structure elements of Pml1p51–204 are shown as blue arrows (β-strands) and red
boxes (helices) above the alignment. TheΔ10 loop of Pml1p is marked by a yellow dashed line. Structurally aligned residues are boxed (compare also with the gray regions in Fig.









Fig. 6. Comparison of Pml1p and NIPP1 highlighting
hotspots for phosphopeptide interaction. Residues in
NIPP1, which are affected by binding of a phospho-
peptide as judged by NMR chemical shift changes,18
are highlighted in blue. Corresponding residues in
Pml1p are shown in green. An elongated phosphopep-
tide bound to Pml1p in a similar fashion as to NIPP1
would point toward the unstructured Δ10 loop region.
The models are rotated 70° around the x-axis compared
with Fig. 1 (left).
Fig. 5. The putative phosphoamino acid-binding region of Pml1p. (a) Residues of Pml1p (left) and Chfr (center)
presumably involved in phosphopeptide binding are shown as sticks and color coded by atom type (carbon is shown in
green and in gray, respectively; oxygen, in red, nitrogen, in blue; sulfur, in yellow; and tungstate, in cyan). Residues of
Rad53p FHA1 (right; carbon is shown in dark blue) in complex with a phosphopeptide (backbone model with a
phosphothreonine residue; carbon is shown in light blue) are shown as sticks. Hydrogen bonds and salt bridges are
indicated by black dashed lines. Models are rotated 130° around the y-axis compared with Fig. 1 (left). (b) 2Fo−Fc
electron density maps of the sulfate-bound (left) and unbound (right) structures of Pml1p contoured at the 1σ level
within a 5-Å distance of Arg108. Black dashed lines represent hydrogen bonds and salt bridges. Amino acids are shown
as sticks. In both structures, the backbone oxygen of Ser136 is engaged in positioning Arg108. Color coding is the same
as in (a).
537Structure of Pml1pabsent from the FHA domains of other proteins (Fig.
4a and b). We therefore suggest that the Δ10 loop
helps determine ligand specificity by engaging in
direct contacts with the phosphopeptide.Discussion
Functional organization of Pml1p
We have shown by crystal structure analysis that
Pml1p exhibits an FHA domain with noncanonical
expansions and insertions (Fig. 2) and that the
ordered portion of the protein is preceded by an
intrinsically unstructured region. A short peptide N-
terminal of the canonical FHA domain lies like a
clamp across one of the β-sheets and protects the
domain against aggregation. A similarly positioned
and highly homologous peptide is found only in
NIPP1,18 another FHA domain protein with a
function in pre-mRNA splicing (Figs. 3a and 4b).
FHA domain proteins often contain additional
functional elements. For instance, in the A. thaliana
KAPP, a central FHA domain is flanked by an N-
538 Structure of Pml1pterminal type I membrane anchor and a C-terminal
protein phosphatase type 2C catalytic domain.24 A
flexible linker probably allows free rotational move-
ment between the FHA and protein phosphatase
type 2C domains.25 Similarly, the PNK FHA domain
is thought to be flexibly linked to the kinase/
phosphatase catalytic domain.14 Here, we have
shown that in Pml1p, a C-terminal FHA domain is
associated with an intrinsically unstructured region
at the N-terminus. This N-terminal part serves to
anchor Pml1p to Snu17p in the RES complex.9
Tethering of Pml1p to Snu17p via a flexible hinge
would allow largely unrestricted movement of the
FHA domain with respect to the scaffold, even if
Snu17p was docked to a massive spliceosome. The
FHA domain could thus reorient in order to interact
with binding partners. A similar situation was
observed in the lateral L7/12 stalk of the 50S ribo-
somal subunit, in which L7/12 C-terminal domains
are flexibly linked to the stalk base, allowing them to
“patrol” neighboring areas in search of elongation
factors.26
The Pml1p FHA domain as a putative
phosphopeptide-binding element
FHA domains are known to serve as phosphor-
ylation sensors by interacting primarily with phos-
phorylated threonine residues in ligand proteins.22
As a prominent example, the FHA domain of mam-
malian PNK targets the enzyme to sites of baseexcision repair and nonhomologous end-joining
repair by interacting with phosphorylated XRCC1
and XRCC4, which are central components of
the respective pathways.22,27–29 Phosphopeptide-
binding FHA domains are also found in pro-
teins associated with pre-mRNA splicing. NIPP1
harbors an FHA domain and interacts with CDC5L
and SF3b155 in a phosphorylation-dependent
manner.30,31 Dominant negative mutants of NIPP1
that block spliceosome assembly at the step of
catalytic activation have been characterized.32
Several structures of FHA domains alone and in
complex with phosphopeptide ligands are avail-
able.12–16,19,22,33–35 In these structures, phosphopep-
tides bind in an extended conformation at one side
of the domain and the phosphoamino acid-binding
site is formed by a set of highly conserved residues.
Our data suggest that the Pml1p FHA domain can
also act as a phosphopeptide-binding domain. First,
interaction of Pml1p with Snu17p leaves the
canonical phosphopeptide-binding site on the FHA
domain available for further interaction with a
phosphoprotein. Second, the Pml1p FHA domain
exhibits all residues critical for phosphopeptide
binding (Fig. 5a). Third, Pml1p can bind a phos-
phate-mimicking sulfate ion at the putative phos-
phoamino acid-binding site (Fig. 5).
Conservation of the structures of full-length
Pml1p (sulfate-bound) and truncated Pml1p (lack-
ing sulfate) in the immediate vicinity of the sulfate-
binding site suggests that the binding site for theFig. 7. Global model of the RES
complex (seeMaterials andMethods).
Snu17p, Pml1p and Bud13p are
shown in blue, green and orange,
respectively. The dark green portion
of the Pml1p structure has been
determined experimentally (residues
51–204). The light green N-terminal
part was modeled using the X-ray
crystal structure of human SF3b14a–
SF3b155 complex as a template.37
The Snu17p–Bud13p interaction
was modeled according to the solu-
tion structure of the U2AF65
(RRM3)–SF1 complex.38 Only the
highly conserved region of Bud13p
involved in the interaction with
Snu17p is shown. “N” indicates N-
termini; “C,” C-termini.
539Structure of Pml1pphosphoamino acid moiety of a putative phospho-
peptide ligand is largely preformed in uncomplexed
Pml1p. On the other hand, the unstructured Δ10
loop is ideally positioned to bind neighboring re-
gions of the phosphopeptide ligand by an induced-
fit mechanism, thereby increasing specificity. A
similar mixed binding strategy has recently been
revealed in complexes involving the spliceosomal
Prp31 protein.36
Presently, it is not known whether the putative
phosphopeptide-binding activity of Pml1p plays a
role during pre-mRNA splicing. Further structural
and functional studies will be required to character-
ize the targets recognized by Pml1p and its exact
mode of action. One interesting observation is that
Snu17p and Pml1p interact with a Kd in the micro-
molar range, significantly higher than the nano-
molar Kd of the Snu17p–Bud13p interaction.
9
Therefore, it is possible that Snu17p recruits Pml1p
intermittently as a flexible phosphorylation sensor
during pre-mRNA retention or splicing.
An architectural model of the RES complex
On the basis of the crystal structure of Pml1p (this
work) and biochemical analyses,9 we have devised a
structural model of the RES core complex centered
on Snu17p (Fig. 7). In the model, short binding
epitopes in the unstructured N-terminal part of
Pml1p and in the C-terminal part of Bud13p come to
lie on two separate binding sites of Snu17p. We have
added the expanded FHA domain structure of
Pml1p determined herein to its Snu17p-binding
peptide. Our model illustrates how Snu17p serves as
a scaffolding molecule that displays a functional
element in Pml1p (the C-terminal FHA domain).†http://www.pepcore.embl.de/cloning/choice_vector/
ecoli_embl.htmlMaterials and Methods
Purification and characterization of Pml1p
Cloning of the gene encoding yeast Pml1p has been
described previously.9 Full-length Pml1pwas expressed in
Escherichia coli Rosetta 2(DE3) cells from a pCDFDuet-1
expression vector (Novagen) N-terminally fused to a
cleavable His6 tag. Transformed cells were grown in LB
medium supplemented with chloramphenicol/strepto-
mycin to an OD600 of 0.8–1.2. After induction with
0.5 mM isopropyl-β-D-thiogalactopyranoside (IPTG),
cells were incubated for 3–4 h at 25 °C before harvesting.
The target protein was captured from soluble extract via
Ni2+-nitrilotriacetic acid (NTA) resin and eluted by
addition of imidazole. The tag was removed by addition
of tobacco etch virus protease (protease/protein mass
ratio=1:40). After buffer exchange to 50 mM Tris–HCl,
pH 7.5, 150 mM NaCl and 1 mM DTT via a 16/10
HighPrep desalting column (GE Healthcare), the protein
solution was loaded onto CM-Sepharose (GE Healthcare),
washed and eluted in a linear gradient to the same buffer
plus 500 mM NaCl. Pooled fractions were further purified
by size-exclusion chromatography on a Superdex 75 26/
60 column (GE Healthcare) in 10 mM Tris–HCl, pH 7.5,
150 mM NaCl and 1 mM DTT. The purified protein was
concentrated to 16 mg/ml with spin concentrators(VIVAscience). The final sample was N98% pure as judged
by SDS-PAGE analysis.
An N-terminally truncated version of Pml1p encom-
passing residues 51–204 (Pml1p51–204), also bearing an
N-terminal cleavable His6 tag, was expressed in E. coli
Rosetta 2(DE3) cells from a pETM-11 vector (EMBL
Heidelberg†, Heidelberg, Germany). The protein was
purified as described for full-length Pml1p but loaded
directly on a Superdex 75 26/60 column (GE Healthcare)
after tobacco etch virus cleavage and was subsequently
cycled over preequilibrated Ni2+-NTA to remove residual
uncleaved fusion protein. The final Pml1p51–204 pool was
concentrated to 34 mg/ml.
Analytical gel-filtration experiments were performed on
a SMART system (GE Healthcare) using a Superdex 75
PC3.2 column equilibrated in 10 mM Tris–HCl, pH 7.5,
150 mM NaCl and 1 mM DTT.
Crystallization of Pml1p
Full-length Pml1p was crystallized by the sitting-drop
vapor-diffusion method using a reservoir comprising
100 mM Tris–HCl, pH 7.5, 200 mM Li2SO4, 21%–24%
PEG (polyethylene glycol) 3350 and IPTG as an additive.
For experimental phasing, Pml1p crystals were incubated
in reservoir solution containing 1 mM Baker's dimercurial
(Hampton Research, Inc.). Soaked crystals were trans-
ferred into reservoir solution containing 1 mM Baker's
dimercurial and 6% polypropylene glycol and were flash
frozen in liquid nitrogen for data collection. Native
crystals were transferred into perfluoropolyether (Hamp-
ton Research, Inc.), and trace amounts of reservoir were
removed before flash freezing in liquid nitrogen.
Pml1p51–204 was crystallized by the hanging-drop
vapor-diffusion technique using a reservoir comprising
75 mM Hepes, pH 7.1, 17% PEG 10000, 15% glycerol and
6.5% ethylene glycol. Crystals appeared after 5 days at
20 °C. For diffraction experiments, crystals were directly
frozen in a liquid nitrogen stream.
Diffraction data collection and crystal structure
determination
A native data set of a full-length Pml1p crystal was
collected at 100 K on beamline BW6 (DESY, Hamburg,
Germany). Crystal symmetry and unit cell dimensions
(Table 1) suggested two Pml1p molecules per asymmetric
unit. Crystals soaked with Baker's dimercurial were
measured at the high-energy side of the Hg-LIII edge on
beamline PXII (SLS, Villigen, Switzerland) and beamline
14-2 (BESSY, Berlin, Germany) and were nonisomorphous
with the native crystals. Diffraction data were processed
using DENZO/Scalepack.39 The structure was solved by
the SAD technique using the SHELX program collection.40
Scaled diffraction data were analyzed using SHELXC. The
heavy atom substructure was solved using SHELXD.
Initial phases were calculated using SHELXE and
improved by solvent flattening. The SAD electron density
map allowed building of β-sheets that could be used as a
search model for phasing of the native data set. The model
was completed by iterative cycles of manual model
building in Coot41 and automated refinement with the
program Refmac5.42 During initial refinement cycles, the
540 Structure of Pml1pmodel was restrained by a 2-fold noncrystallographic
symmetry.
Diffraction data of a Pml1p51–204 crystal were measured
on beamline PXII of SLS and processed as described
above. Crystal symmetry and unit cell dimensions (Table
1) suggested one Pml1p51–204 molecule per asymmetric
unit. The structure was solved by molecular replacement
with the program Molrep43 using the structure coordi-
nates of the full-length protein. Automated refinement
and building of the water structure were done with
Refmac5, and the model was manually adjusted by using
Coot.
The final structural models were validated with CNS44
by calculating simulated annealing composite omit maps
covering the entire asymmetric units of the two crystal
forms. Secondary structure elements were assigned with
the program DSSP.45
Structural modeling
A global architectural model of the RES complex was
devised by combining the present crystal structure of
Pml1p and the model of the Snu17p RRM in complex with
binding peptides of Pml1p and Bud13p.9 The peptide
representing Pml1p was connected to the crystal structure
of the folded portion of Pml1p by manually inserting the
corresponding number of alanine residues. The Pml1p
FHA domain and the Snu17p RRM were oriented arbit-
rarily relative to each other. All of the manual modeling
was done with Coot.
Protein Data Bank accession code
Coordinates and structure factors have been deposited
with the Protein Data Bank with accession numbers 3ELV
(full-length Pml1p) and 3ELS (Pml1p51–204).Acknowledgements
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